o2h-ventures

Oppilotech have developed a unique high-resolution platform based on systems biology and machine learning to model biological processes in cells. The platform is utilized to identify first-in-class viable drug targets and to develop novel modes of action drugs modulating the identified targets. Three first-in-class antibacterial drug targets and generated active chemical matter against 2 of them.

Applying High-Resolution Dynamic Modelling Platform to model pathways in mammalian cells implicated in cancer
Status Active
Website http://oppilotech.com/
Category AI & Biotech
Modality Small Molecule
Therapautics Area Anti-infectives
Headquaters London, UK
Partner Innovate UK Babraham Accelrator Francis Crick Institute
Investment Portfolio Pre-Fund Investment